欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0126/001
药品名称FSME-Immun 0,25 ml Junior
活性成分
    • Tick-borne-encephalitis virus, inactivated 1.2 µg
剂型Suspension for injection
上市许可持有人Pfizer Corporation Austria Gesellschaft m.b.H. Floridsdorfer Hauptstraße 1 1210 Wien
参考成员国 - 产品名称Austria (AT)
FSME-Immun 0,25 ml Junior Injektionssuspension in einer Fertigspritze
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
      TicoVac 1,2µg/dozėje injekcinė suspensija užpildytame švirkšte
    • Estonia (EE)
    • Hungary (HU)
    • Czechia (CZ)
    • Slovakia (SK)
    • Slovenia (SI)
    • Greece (GR)
    • Romania (RO)
    • Croatia (HR)
    • Malta (MT)
许可日期2003/06/06
最近更新日期2025/06/10
药物ATC编码
    • J07BA01 encephalitis, tick borne, inactivated, whole virus
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Article 4.8 Di 65/65
  • TypeLevel4：Biological: Vaccine
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase